Alkali Metal Salt Formulations for Improved AMPK Drug Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need to improve the bioavailability of 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide for enhanced effectiveness in medical treatments targeting metabolic disorders, cancer, cardiovascular diseases, and other conditions.
Innovation Solution
The use of alkali metal salts, particularly sodium or potassium salts, of 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide, combined with milling to reduce particle size, enhances bioavailability by increasing systemic exposure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If the free base form of 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide is used, then the formulation is simple, but the bioavailability is insufficient
Solution Approach 1:
The patent converts the free base form of the active ingredient into alkali metal salt forms (sodium, potassium, lithium salts). This chemical parameter change fundamentally alters the dissolution and absorption characteristics of the compound, resulting in significantly enhanced bioavailability without requiring complex formulation strategies
Solution Approach 2:
Alkali metal salts serve as intermediaries that facilitate the transition of the active ingredient from poor absorption (free base form) to high absorption (salt form). These salt forms act as mediators that improve the interaction between the active ingredient and the biological system, enabling better bioavailability
2Stability of the object's composition
If stabilizers are added to improve formulation stability, then the stability is enhanced, but the formulation complexity increases
Solution Approach 1:
The alkali metal salt forms of the active ingredient possess inherent stability characteristics that do not require external stabilizers for maintenance. The salt forms themselves provide the necessary stability through their chemical structure, eliminating the need for additional stabilizing agents and simplifying the overall formulation
Data Source
AI summary
There is provided an alkali metal salt of 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide and formulations thereof. This salt finds particular utility in the treatment or prevention of a disorder or condition ameliorated by the activation of AMPK.